Literature DB >> 9072003

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.

R Villuendas1, F Pezzella, K Gatter, P Algara, M Sánchez-Beato, P Martínez, J C Martínez, K Muñoz, P García, L Sánchez, S Kocialkowsky, E Campo, J L Orradre, M A Piris.   

Abstract

p53 is a tumour suppressor gene which is often found to be inactivated in most types of human cancer. p53 is a transcription factor, the inactivation of which may lead to significant variations in the levels of p53 downstream proteins, such as p21WAF1/CIP1 and MDM2. In view of the significance of p21WAF1/CIP1 and MDM2 as wild-type (wt) p53 targets, this study was undertaken to monitor the varying expression of these proteins in non-Hodgkin's lymphomas (NHLs) in relation to p53 gene status. A total of 57 cases of different histological types of NHL were included in this study. Proteins p53, p21WAF1/CIP1, and MDM2 were analysed by immunohistochemical techniques, taking the levels expressed in reactive lymphoid tissues as reference points. p53 gene point mutations (exons 5-8) were looked for using the PCR-SSCP technique and direct sequencing. Fifteen of the 57 cases studied showed 16 mutations at the p53 gene: 12 missense, one nonsense, two silent mutations, and one frameshift deletion. Most missense mutations were associated with high levels of p53 protein, while the nonsense mutations and frameshift deletion did not induce detectable levels of p53. All cases with mutation at the p53 gene (15) showed null or low levels of p21WAF1/CIP1 and MDM2 proteins, suggesting that null or missense mutations at this gene give rise to a protein that is unable to transactivate the p21WAF1/CIP1 and MDM2 genes. The association between missense p53 mutation and dissociate immunophenotype (p53+, MDM2-, p21-) was statistically significant (Fisher's exact test, P = 0.0024). This anomalous p53+, MDM2-, p21- phenotype was also found in a small group of five cases with wt p53; this could indicate that in these cases p53 transactivation capacity has been abrogated by a mechanism other than p53 mutation. Most cases with the wt p53 gene show simultaneous immunohistochemical expression of all three proteins and often display higher levels than those found in reactive lymphoid tissue. There is a tendency for EBV-positive cases to harbour high levels of p53+ and p21+, suggesting that EBV could be involved in the nuclear accumulation of p53 and p21WAF1/CIP1 in NHL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9072003     DOI: 10.1002/(SICI)1096-9896(199701)181:1<51::AID-PATH689>3.0.CO;2-N

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  11 in total

1.  Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas.

Authors:  M Sol Mateo; M Mollejo; R Villuendas; P Algara; M Sánchez-Beato; B Martinez-Delgado; P Martínez; M A Piris
Journal:  Mol Pathol       Date:  1998-10

2.  Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.

Authors:  C R Antonescu; D H Leung; M Dudas; M Ladanyi; M Brennan; J M Woodruff; C Cordon-Cardo
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

Authors:  M Sánchez-Beato; A I Sáez; I C Navas; P Algara; M Sol Mateo; R Villuendas; F Camacho; A Sánchez-Aguilera; E Sánchez; M A Piris
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

Authors:  Abhik Saha; Masanao Murakami; Pankaj Kumar; Bharat Bajaj; Karen Sims; Erle S Robertson
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

5.  Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.

Authors:  M Sánchez-Beato; A I Sáez; J C Martínez-Montero; M Sol Mateo; L Sánchez-Verde; R Villuendas; G Troncone; M A Piris
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

6.  p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.

Authors:  L Quintanilla-Martinez; M Kremer; G Keller; M Nathrath; A Gamboa-Dominguez; A Meneses; L Luna-Contreras; A Cabras; H Hoefler; A Mohar; F Fend
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

7.  Alterations in MDM2 expression in esophageal squamous cell carcinoma: relationship with p53 status.

Authors:  S Arora; R Mathew; M Mathur; T K Chattopadhayay; R Ralhan
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma.

Authors:  Nilay Sethi; Osamu Kikuchi; James McFarland; Yanxi Zhang; Max Chung; Nicholas Kafker; Mirazul Islam; Benjamin Lampson; Abhishek Chakraborty; William G Kaelin; Adam J Bass
Journal:  JCI Insight       Date:  2019-08-08

9.  p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas.

Authors:  Begona Arribas; Eva Cristobal; Jose A. Alcazar; Juan Tardio; Juan C. Matinez-Montero; Jose R. Polo; Rafael Carrion; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

10.  Lymphoepithelioma-like carcinoma of the bladder: three cases with clinicopathological and p53 protein expression study.

Authors:  Francisco Miguel Izquierdo-García; Fructuoso García-Díez; Isabel Fernández; Alberto Pérez-Rosado; Anabel Sáez; Dimas Suárez-Vilela; Rafael Guerreiro-González; Manuel Benéitez-Alvarez
Journal:  Virchows Arch       Date:  2004-04-06       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.